» Articles » PMID: 12690108

CD47 and the 19 KDa Interacting Protein-3 (BNIP3) in T Cell Apoptosis

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Apr 12
PMID 12690108
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

CD47 is a surface receptor that induces either coactivation or apoptosis in lymphocytes, depending on the ligand(s) bound. Interestingly, the apoptotic pathway is independent of caspase activation and cytochrome c release and is accompanied by early mitochondrial dysfunction with suppression of mitochondrial membrane potential (Deltapsim). Using CD47 as bait in a yeast two-hybrid system, we identified the Bcl-2 homology 3 (BH3)-only protein 19 kDa interacting protein-3 (BNIP3), a pro-apoptotic member of the Bcl-2 family, as a novel partner. Interaction between CD47 and the BH3-only protein was confirmed by immunoprecipitation analysis, and CD47-induced apoptosis was inhibited by attenuating BNIP3 expression with antisense oligonucleotides. Finally, we showed that the C-terminal domain of thrombospondin-1 (TSP-1), but not signal-regulatory protein (SIRPalpha1), is the ligand for CD47 involved in inducing cell death. Immunofluorescence analysis of CD47 and BNIP3 revealed a partial colocalization of both molecules under basal conditions. After T cell stimulation via CD47, BNIP3 translocates to the mitochondria to induce apoptosis. These results show that the BH3-dependent apoptotic pathways, previously shown to be activated by intracellular pro-apoptotic events, can also be turned on by surface receptors. This new pathway results in a fast induction of cell death resembling necrosis, which is likely to play an important role in lymphocyte regulation at inflammatory sites and/or in the vicinity of thrombosis.

Citing Articles

Deciphering the role of CD47 in cancer immunotherapy.

Liu Y, Weng L, Wang Y, Zhang J, Wu Q, Zhao P J Adv Res. 2024; 63:129-158.

PMID: 39167629 PMC: 11380025. DOI: 10.1016/j.jare.2023.10.009.


Cell autonomous functions of CD47 in regulating cellular plasticity and metabolic plasticity.

Polara R, Ganesan R, Pitson S, Robinson N Cell Death Differ. 2024; 31(10):1255-1266.

PMID: 39039207 PMC: 11445524. DOI: 10.1038/s41418-024-01347-w.


Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis.

Xu L, Wang X, Zhang T, Meng X, Zhao W, Pi C Cell Rep Med. 2024; 5(3):101450.

PMID: 38508139 PMC: 10983038. DOI: 10.1016/j.xcrm.2024.101450.


Structural-functional diversity of CD47 proteoforms.

Zhang T, Wang F, Xu L, Yang Y Front Immunol. 2024; 15:1329562.

PMID: 38426113 PMC: 10902115. DOI: 10.3389/fimmu.2024.1329562.


CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer.

Lau A, Khavkine Binstock S, Thu K Cancers (Basel). 2023; 15(21).

PMID: 37958404 PMC: 10649163. DOI: 10.3390/cancers15215229.